The objective of this section is to serve as a doctor’s window to the world of stem cells. This section includes sufficient scientific stem cell updates sourced from clinical publications, latest researches, clinical trials and therapeutic applications to equip doctors into top notch clinicians. This would enable doctors to offer latest technological up gradations to their patients to bring out the best outcomes.
Connecting the biological dots of human immortality
The new millennium meaningfully seems to move ahead to become the golden phase of biological research. Having had the jackpot discoveries and inventions in the last century in the field of Biology, it looks like that those are now tending to a new phase of research.
How can stem cell therapy help in the treatment of Parkinson’s Disease?
Parkinson’s disease is a progressive neurodegenerative condition that affects the nerves cells of the central nervous system. At the onset, it manifests itself with milder symptoms like walking and then progresses into severe traumatic symptoms such as depression, emotional instability, and abnormal sleep patterns.
Neuroblastoma is a type of extracranial childhood cancer that is usually found in the tissue of adrenal gland that sits atop the kidney. This tumour can also develop in or spread to other parts of the body such as the spine, spinal cord, chest, neck, and pelvis. By the time it is diagnosed, it may spread to tissues beyond the original site such as bone marrow, bone, lymph, nodes, liver, and skin.
Stem Cells Gift A New Lease of Life to Multiple Myeloma Patients
Multiple Myeloma (MM) is a cancer formed by malignant plasma cells. Plasma cells when affected by cancer multiply abnormally and develop multiple tumours called Multiple Myeloma. It initially affects the bones causing bone lesions and later spreads to the other organs causing multiple organ damage.
Successful Clinical outcome of Autologous haemopoietic stem cells transplant on patients with Multiple Sclerosis
Three Canadian hospitals conducted a phase 2 single arm clinical trial on a same set of Multiple Sclerosis patients using Immunoablation followed by immune cell depleted Autologous Haemopoietic Stem cells Transplantation and noted their outcomes for a median period of 6-7 years .
Autologous Stem Cell Transplant conquers Lymphoma in HIV patients
Researches furnished at City Hope National Medical Centre, in Duarte, California USA, reveal that stem cell therapy can be of real value to HIV patients with Lymphoma, proving HIV positives, eligible for stem cell transplant for the first time.